Product
scAAV9.U7.ACCA
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
Phase I/IIa Systemic Gene Delivery Clinical Trial of scAAV9.U7.ACCA for Exon 2 Duplication-Associated Duchenne Muscular DystrophyStatus: Active (not recruiting), Estimated PCD: 2023-11-19